+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nanomedicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5483607
  • Report
  • November 2021
  • Region: Global
  • 145 Pages
  • IMARC Group

FEATURED COMPANIES

  • Abbott Laboratories
  • General Electric Company
  • Luminex Corporation
  • Merck & Co. Inc.
  • Nanobiotix
  • Novartis AG
The global nanomedicine market exhibited strong growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level. It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body. As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.

Nanomedicine Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for nanomedicines to produce vaccines and nanocarrier systems with enhanced efficacies. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market. Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global nanomedicine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, nanomolecule type, product and application.

Breakup by Nanomolecule Type:

  • Nanoparticles
  • Metal and Metal Oxide Nanoparticles
  • Liposomes
  • Polymers and Polymer Drug Conjugates
  • Hydrogel Nanoparticles
  • Dendrimers
  • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

Breakup by Product:

  • Therapeutics
  • Regenerative Medicine
  • In-Vitro diagnostics
  • In-Vivo diagnostics
  • Vaccines

Breakup by Application:

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.

Key Questions Answered in This Report:

  • How has the global nanomedicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nanomedicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the nanomolecule type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nanomedicine market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • General Electric Company
  • Luminex Corporation
  • Merck & Co. Inc.
  • Nanobiotix
  • Novartis AG

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nanomedicine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Nanomolecule Type
6.1 Nanoparticles
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Metal and Metal Oxide Nanoparticles
6.1.2.2 Liposomes
6.1.2.3 Polymers and Polymer Drug Conjugates
6.1.2.4 Hydrogel Nanoparticles
6.1.2.5 Dendrimers
6.1.2.6 Inorganic Nanoparticles
6.1.3 Market Forecast
6.2 Nanoshells
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Nanotubes
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nanodevices
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Product
7.1 Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Regenerative Medicine
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In-Vitro Diagnostics
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 In-Vivo Diagnostics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Vaccines
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Clinical Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Infectious Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Cardiology
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Orthopedics
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Arrowhead Pharmaceuticals Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 General Electric Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Luminex Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Merck & Co. Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Nanobiotix
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi SA
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Starpharma Holdings Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
List of Figures
Figure 1: Global: Nanomedicine Market: Major Drivers and Challenges
Figure 2: Global: Nanomedicine Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Nanomedicine Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Nanomedicine Market: Breakup by Nanomolecule Type (in %), 2020
Figure 5: Global: Nanomedicine Market: Breakup by Product (in %), 2020
Figure 6: Global: Nanomedicine Market: Breakup by Application (in %), 2020
Figure 7: Global: Nanomedicine Market: Breakup by Region (in %), 2020
Figure 8: Global: Nanomedicine (Nanoparticles) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Nanomedicine (Nanoparticles) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Nanomedicine (Nanoshells) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Nanomedicine (Nanoshells) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Nanomedicine (Nanotubes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Nanomedicine (Nanotubes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Nanomedicine (Nanodevices) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Nanomedicine (Nanodevices) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Nanomedicine (Therapeutics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Nanomedicine (Therapeutics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Nanomedicine (Regenerative Medicine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Nanomedicine (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Nanomedicine (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Nanomedicine (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Nanomedicine (In-Vivo Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Nanomedicine (In-Vivo Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Nanomedicine (Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Nanomedicine (Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Nanomedicine (Clinical Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Nanomedicine (Clinical Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Nanomedicine (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Nanomedicine (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Nanomedicine (Clinical Cardiology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Nanomedicine (Clinical Cardiology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Nanomedicine (Orthopedics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Nanomedicine (Orthopedics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Nanomedicine (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Nanomedicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: North America: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: North America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: United States: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: United States: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Canada: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Canada: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Asia-Pacific: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Asia-Pacific: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: China: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: China: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Japan: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Japan: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: India: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: India: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: South Korea: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: South Korea: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Australia: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Australia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Indonesia: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Indonesia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Others: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Europe: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Europe: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Germany: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Germany: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: France: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: France: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: United Kingdom: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: United Kingdom: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Italy: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Italy: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Spain: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Spain: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Russia: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Russia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Others: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Latin America: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Latin America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Brazil: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Brazil: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Mexico: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Mexico: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Others: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Middle East and Africa: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Middle East and Africa: Nanomedicine Market: Breakup by Country (in %), 2020
Figure 84: Middle East and Africa: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Global: Nanomedicine Industry: SWOT Analysis
Figure 86: Global: Nanomedicine Industry: Value Chain Analysis
Figure 87: Global: Nanomedicine Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Nanomedicine Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Nanomedicine Market Forecast: Breakup by Nanomolecule Type (in Million US$), 2021-2026
Table 3: Global: Nanomedicine Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 4: Global: Nanomedicine Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Nanomedicine Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Nanomedicine Market: Competitive Structure
Table 7: Global: Nanomedicine Market: Key Players
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals Inc.
  • General Electric Company
  • Luminex Corporation
  • Merck & Co. Inc.
  • Nanobiotix
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Starpharma Holdings Limited.
Note: Product cover images may vary from those shown

Loading
LOADING...